Move over karyotypes—genetic disorder detection has vastly improved. Researchers are now using array CGH (aCGH), to quickly scan through an entire genome for imbalances. Because aCGH facilitates ...

Molecular biomarkers can serve as useful diagnostic markers, as prognostic markers for predicting clinical behavior, or as targets for new therapeutic strategies. Application of expression microarray ...

Mitchell Grant is a self-taught investor with over 5 years of experience as a financial trader. He is a financial content strategist and creative content editor. Suzanne is a content marketer, writer, ...

Bionano Genomics achieved a 4% year-over-year revenue growth. Consumable revenue increased by 20% year-over-year. Adjusted gross margin improved to 49%, up from 46% in the previous year. The company ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Earnings call Bionano Genomics delivered Q1 2026 revenue of $6.7M, up 4% YoY and at the high end of guidance, with consumable revenue up 20% and flow cell unit sales up 17%. Adjusted gross margin ...